Novartis donates Rs 16 Crore gene therapy to 23 month old Spinal Muscular Atrophy Type 1 patient - Video
|
Overview
A 23-month-old baby with Spinal Muscular Atrophy (SMA) Type 1, received a new lease of life with Swiss drugmaker Novartis coming forward to donate gene therapy costing Rs 16 crore.
Baby Ellen was administered Zolgensma gene therapy, called the world's costliest drug, at a private hospital in Hyderabad on August 6, her father Rayapudi Praveen said on Sunday.
For more details, check out the full story on the link mentioned below:
Novartis Donates Rs 16 Crore Drug To 23 Month Old Spinal Muscular Atrophy Type 1 Patient
Speakers
Roshni Dhar, a Mass com graduate with a soft corner for health happenings, joined Medical Dialogues as a news anchor in 2021. Inspired by her mother who is a gynaecologist, she likes to keep herself and the world updated on the occurring in the medical field. She covers various aspects of health news for MDTV at Medical Dialogues. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751